Browse Guides  internal medicine  cardiology

Acute coronary syndrome

Prevalence
Clinical features
Differential diagnosis
Investigations
Therapy
Prevention
Prognosis
Therapy

Consider admitting your patient to a chest pain observation unit d

Treat symptoms rather than ECG changes d

Give

  • oxygen d
  • aspirin 75 to 325 mg long-term a and clopidogrel a (300 mg loading dose, followed by 75 mg daily for up to 12 months)

Less effective alternatives include ticlopidine a  

with a any of

  • a low-molecular weight heparin (LMWH) a for up to 7 days (e.g. enoxaparin 1 mg/kg daily) a
  • heparin d  
  • hirudin a
Give intravenous a or buccal nitroglycerin for chest pain  a  
(if intravenous, give 1 mg/ml; titrated from 1.5 ml/hour to 12 ml/hour. If 20% reduction in blood pressure or 10% decrease in heart rate, or headache, stop titration at that level.)  

Start a beta-blocker a or a calcium channel blocker (e.g. dilitazem a or verapamil) a  
For patients already on a beta-blocker, add a calcium channel blocker a
For patients already on calcium channel blockers, add a beta-blocker a if possible

Consider adding long-acting nitrates c

With ECG changes or elevated cardiac enzymes

  • Add a platelet glycoprotein IIb/IIIa inhibitor a e.g. tirofiban or eptifibatide a
    Avoid using 
    • abciximab a
    • oral glycoprotein IIb/IIIa inhibitors. a

    There is no clear benefit from using 

    • a platelet glycoprotein IIb/ IIIa inhibitor alone. d  
    • lamifiban d

For patients with any of the following:

  • new ST depression of at least 0.5 mm, transient (< 20 min) ST elevation of at least 1 mm, or T wave inversion of at least 3 mm in 2 or more leads
  • elevated cardiac markers
  • history of coronary disease from catheterisation, revascularisation or myocardial infarction
arrange for urgent angiography and revascularisation if required as soon as possible a

With severe refractory ischaemia

Consider

  • adding a glycoprotein IIb/ IIIa inhibitor a  
  • adding nicorandil a  
  • thoracic epidural anaesthesia a  
  • adding n-acetylcysteine to nitrates a b
  • angiography and revascularisation

There is no clear benefit from thrombolysis a 

Avoid anticoagulation a

Angioplasty

Offer angioplasty to patients with single vessel disease b  

Assess your patient for risk of complications a before deciding on angioplasty 

  • Look for
    • aortic valve disease a  
    • shock a  
    • acute myocardial infarction within 24 hours of coronary angioplasty a
    • unstable angina a b  
    • complex lesion on coronary angioplasty a b
    • left main coronary artery lesions a  
    • multivessel disease a b

Arrange for angioplasty by an experienced physician in a busy centre. b 

Give a glycoprotein IIb/ IIIa antagonist a e.g. abciximab and heparin b   

Insert a stent in new a and chronic occlusions a  
Following stent insertion, give clopidogrel 300 mg bolus a, then 75 mg daily for one month. a  

Consider 

  • giving probucol a
  • intracoronary gamma radiation therapy following opening of stenosed coronary stents a

There is no clear benefit from:

  • atherectomy a  
  • multivitamins a  

Coronary artery bypass surgery

Offer coronary artery bypass surgery to patients with
  • multivessel disease or left main artery disease a
  • poor left ventricular function a
  • severe angina a
  • an abnormal exercise tolerance test a
However the procedure is more risky than angioplasty. a  

Consider giving acadesine perioperatively. a  

Refractory angina, but unfit for angioplasty or CABG

Offer any of 

  • transmyocardial laser revascularisation a
  • spinal cord stimulation surgery  a  

 

 

Expiry date: June 2003
Levels of Evidence used in grading these guides

Authors   CM   Ball , N   Shenker
Reviewer   I K   Jang
CAT Writers   N   Shenker , CJ   Wotton , CM   Ball , RS   Phillips